Bb Biotech as of March 31, 2016
Portfolio Holdings for Bb Biotech
Bb Biotech holds 29 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 14.4 | $361M | 3.6M | 100.09 | |
| Incyte Corporation (INCY) | 11.1 | $278M | 3.8M | 72.47 | |
| Ionis Pharmaceuticals (IONS) | 10.9 | $275M | 6.8M | 40.50 | |
| Gilead Sciences (GILD) | 10.1 | $255M | 2.8M | 91.86 | |
| Alexion Pharmaceuticals | 5.7 | $144M | 1.0M | 139.22 | |
| Radius Health | 5.5 | $137M | 4.4M | 31.44 | |
| Neurocrine Biosciences (NBIX) | 4.9 | $124M | 3.1M | 39.55 | |
| Medivation | 4.7 | $119M | 2.6M | 45.98 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $109M | 1.4M | 79.49 | |
| Agios Pharmaceuticals (AGIO) | 3.5 | $88M | 2.2M | 40.60 | |
| Alnylam Pharmaceuticals (ALNY) | 3.0 | $75M | 1.2M | 62.77 | |
| Regeneron Pharmaceuticals (REGN) | 2.9 | $74M | 205k | 360.44 | |
| Halozyme Therapeutics (HALO) | 2.8 | $70M | 7.4M | 9.47 | |
| Tesaro | 2.1 | $54M | 1.2M | 44.03 | |
| Juno Therapeutics | 2.0 | $50M | 1.3M | 38.09 | |
| Novavax | 1.7 | $43M | 8.3M | 5.16 | |
| Alder Biopharmaceuticals | 1.5 | $37M | 1.5M | 24.49 | |
| Cempra | 1.4 | $36M | 2.0M | 17.52 | |
| Kite Pharma | 1.4 | $34M | 750k | 45.91 | |
| Intercept Pharmaceuticals In | 1.3 | $33M | 256k | 128.47 | |
| Sage Therapeutics (SAGE) | 1.1 | $27M | 834k | 32.06 | |
| Esperion Therapeutics (ESPR) | 0.7 | $17M | 1.0M | 16.91 | |
| Infinity Pharmaceuticals (INFIQ) | 0.6 | $14M | 2.7M | 5.27 | |
| Prothena (PRTA) | 0.6 | $14M | 350k | 41.16 | |
| Puma Biotechnology (PBYI) | 0.5 | $13M | 432k | 29.37 | |
| Clovis Oncology | 0.4 | $10M | 528k | 19.20 | |
| Achillion Pharmaceuticals | 0.4 | $9.9M | 1.3M | 7.72 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.4 | $9.5M | 747k | 12.70 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $7.6M | 1.2M | 6.44 |
